ArticleBlood advances2021

Pre-HCT mosaicism increases relapse risk and lowers survival in acute lymphoblastic leukemia patients post-unrelated HCT.

Yiwen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.